Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- vadadustat
- epirubicin
Interactions between your drugs
epiRUBicin vadadustat
Applies to: epirubicin, vadadustat
MONITOR: The concomitant or sequential use of epirubicin with agents known to induce hepatotoxicity may potentiate the risk of liver injury. Epirubicin undergoes elimination through the hepatobiliary system.
MANAGEMENT: Caution and clinical and laboratory monitoring for signs of liver injury are advisable before, during, or after use of epirubicin with other agents that are potentially hepatotoxic.
References (3)
- (2001) "Product Information. Ellence (epirubicin)." Pharmacia and Upjohn
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
Drug and food interactions
vadadustat food
Applies to: vadadustat
MONITOR: Smoking and alcohol consumption during therapy with vadadustat may increase the risk of gastrointestinal erosions. Serious erosions, including gastrointestinal bleeding and the need for red blood cell transfusions, have been reported during vadadustat clinical trials. Patients with a history of gastrointestinal erosion, peptic ulcer disease, and current tobacco smokers and alcohol drinkers may be at higher risk of gastrointestinal injury.
MANAGEMENT: Caution is advised if vadadustat is prescribed to current tobacco smokers or alcohol drinkers. Patients should be advised to contact their physician if they develop potential signs and symptoms of gastrointestinal injury such as abdominal pain, hematemesis, trouble swallowing, chest or throat pain, and/or black, tarry stools.
References (3)
- (2023) "Product Information. Vafseo (vadadustat)." Adjutor Healthcare Pty Ltd
- (2024) "Product Information. Vafseo (vadadustat)." Akebia Therapeutics
- (2024) "Product Information. Vafseo (vadadustat)." Medice UK Ltd
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
FeroSul
FeroSul is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
Infed
Infed is used for anemia due to chronic kidney disease, iron deficiency anemia
Botox
Botox is used to treat chronic migraines, excessive sweating, bladder conditions, eye muscle ...
Aranesp
Aranesp (darbepoetin alfa) is used to treat anemia - a lack of red blood cells in the body ...
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Epogen
Epogen is used to treat anemia (a lack of red blood cells in the body). Learn about side effects ...
Retacrit
Retacrit is used for anemia, anemia due to chronic kidney disease, anemia prior to surgery, anemia ...
Feraheme
Feraheme infusion is used to treat iron deficiency anemia. Learn about side effects, interactions ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.